Ningbo Menovo Pharmaceutical, a wholly-owned subsidiary of Menovo Pharmaceutical (603538.SH), announced on June 25th that it has recently received the Drug Registration Certificate for Glucosamine Sulfate Capsules from the National Medical Products Administration. The drug is used for the treatment of primary and secondary osteoarthritis.
美诺华(603538.SH)：全资子公司获得硫酸氨基葡萄糖胶囊药品注册证书
Ningbo Menovo Pharmaceutical (603538.SH): Wholly-owned subsidiary obtained pharmaceutical registration certificate for ammonium sulfate glucosamine capsules.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.